CANO-ACIO CLINICAL LECTURESHIP the Development and Implementation of a Subcutaneous Immunoglobulin (SCIG) Program at CancerCare Manitoba

Canadian Oncology Nursing Journal
doi 10.5737/23688076262137144
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pappin Communications

Related search

Improved Treatment Satisfaction With a New Human Subcutaneous Immunoglobulin (SCIG 20%) in Patients Previously Treated With IVIG

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Development of Dose Volume Histogram Analysis Program and Its Clinical Implementation

Nippon Hoshasen Gijutsu Gakkai zasshi
Medicine
2016English

Implementation of a Clinical Research Pharmacogenomics Program at an Academic Medical Center: Role of the Genetics Healthcare Professional

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2013English

The Manitoba Community Intrevenous Therapy Program: Then and Now

Canadian Journal of Infectious Diseases
2000English

Subcutaneous Immunoglobulin in Treating Inflammatory Neuromuscular Disorders

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2015English

Development and Implementation of Clinical Trial Protocol Templates at the National Institute of Allergy and Infectious Diseases

Clinical Trials
MedicinePharmacology
2009English

Immunoglobulin Replacement Treatment by Rapid Subcutaneous Infusion

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1998English

The Practice and Challenges of Practicum Implementation Program at a Malaysian Teacher Education Institute

JOURNAL OF SOCIAL SCIENCE RESEARCH
2019English

A New 20% Concentration Immunoglobulin for Subcutaneous Administration (IGSC 20%)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy